|
|
 |
|
Total Number of Holdings (excluding cash): 49
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
953 |
$79,661.27 |
2.54% |
| Penumbra, Inc. |
PEN |
70975L107 |
331 |
$79,175.20 |
2.52% |
| Masimo Corporation |
MASI |
574795100 |
478 |
$78,846.10 |
2.51% |
| Insulet Corporation |
PODD |
45784P101 |
289 |
$77,041.62 |
2.45% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
139 |
$75,312.98 |
2.40% |
| DexCom, Inc. |
DXCM |
252131107 |
972 |
$73,133.28 |
2.33% |
| Stryker Corporation |
SYK |
863667101 |
189 |
$72,893.52 |
2.32% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
228 |
$71,058.48 |
2.26% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
650 |
$71,025.50 |
2.26% |
| Boston Scientific Corporation |
BSX |
101137107 |
772 |
$69,611.24 |
2.22% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
987 |
$68,635.98 |
2.19% |
| Align Technology, Inc. |
ALGN |
016255101 |
303 |
$67,832.61 |
2.16% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,434 |
$67,831.67 |
2.16% |
| ResMed Inc. |
RMD |
761152107 |
280 |
$67,634.00 |
2.15% |
| Abbott Laboratories |
ABT |
002824100 |
579 |
$67,123.47 |
2.14% |
| Waters Corporation |
WAT |
941848103 |
188 |
$67,260.76 |
2.14% |
| Terumo Corporation |
4543.JP |
J83173104 |
3,360 |
$66,175.49 |
2.11% |
| Cochlear Limited |
COH.AU |
Q25953102 |
341 |
$66,071.93 |
2.10% |
| Hologic, Inc. |
HOLX |
436440101 |
843 |
$65,787.72 |
2.09% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
200 |
$64,738.00 |
2.06% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
521 |
$64,847.20 |
2.06% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,965 |
$64,551.53 |
2.06% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,736 |
$63,669.58 |
2.03% |
| Medtronic Plc |
MDT |
G5960L103 |
753 |
$63,334.83 |
2.02% |
| Becton, Dickinson and Company |
BDX |
075887109 |
284 |
$63,158.76 |
2.01% |
| Hoya Corporation |
7741.JP |
J22848105 |
494 |
$63,274.29 |
2.01% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
739 |
$62,741.10 |
2.00% |
| Steris Plc |
STE |
G8473T100 |
296 |
$62,826.00 |
2.00% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
182 |
$62,418.82 |
1.99% |
| The Cooper Companies, Inc. |
COO |
216648501 |
630 |
$62,420.40 |
1.99% |
| Revvity, Inc. |
RVTY |
714046109 |
554 |
$61,682.36 |
1.96% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,166 |
$61,073.49 |
1.94% |
| Agilent Technologies, Inc. |
A |
00846U101 |
468 |
$60,170.76 |
1.92% |
| Baxter International Inc. |
BAX |
071813109 |
1,841 |
$60,071.83 |
1.91% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
9,278 |
$59,897.08 |
1.91% |
| Alcon Inc. |
ALC.SW |
H01301128 |
696 |
$59,336.84 |
1.89% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,734 |
$58,360.03 |
1.86% |
| BioMerieux |
BIM.FP |
F1149Y232 |
564 |
$57,953.73 |
1.85% |
| Danaher Corporation |
DHR |
235851102 |
249 |
$58,041.90 |
1.85% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
113 |
$57,950.92 |
1.85% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
327 |
$57,914.06 |
1.84% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,540 |
$57,303.84 |
1.82% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
926 |
$55,529.14 |
1.77% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,243 |
$54,913.13 |
1.75% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,092 |
$54,898.28 |
1.75% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
441 |
$54,984.82 |
1.75% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
46 |
$53,677.40 |
1.71% |
| Teleflex Incorporated |
TFX |
879369106 |
285 |
$53,417.55 |
1.70% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
948 |
$49,959.60 |
1.59% |
| US Dollar |
$USD |
|
2,598 |
$2,598.06 |
0.08% |
| Japanese Yen |
$JPY |
|
118,638 |
$763.24 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.05 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.09 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|